Country-specific lockdown measures in response to the COVID-19 pandemic and its impact on tuberculosis control: a global study
J Bras Pneumol. 2022 Apr 20;48(2):e20220087.
doi: 10.36416/1806-3756/e20220087.
eCollection 2022.
[Article in
English,
Portuguese]
Authors
Giovanni Battista Migliori
1
, Pei Min Thong
2
, Jan-Willem Alffenaar
3
4
5
, Justin Denholm
6
7
, Marina Tadolini
8
9
, Fatma Alyaquobi
10
, Seif Al-Abri
11
, François-Xavier Blanc
12
, Danilo Buonsenso
13
, Jeremiah Chakaya
14
15
, Jin-Gun Cho
4
16
, Luigi Ruffo Codecasa
17
, Edvardas Danila
18
, Raquel Duarte
19
, Rada Dukpa
20
, José-María García-García
21
, Gina Gualano
22
, Xhevat Kurhasani
23
24
, Katerina Manika
25
, Fernanda Carvalho de Queiroz Mello
26
, Kristin Pahl
27
, Adrian Rendon
28
, Giovanni Sotgiu
29
, Mahamadou Bassirou Souleymane
30
, Tania A Thomas
31
, Simon Tiberi
32
33
, Heinke Kunst
32
33
, Zarir F Udwadia
34
, Delia Goletti
22
, Rosella Centis
1
, Lia D'Ambrosio
35
, Denise Rossato Silva
36
Affiliations
- 1 . Istituti Clinici Scientifici Maugeri - IRCCS - Tradate, Italia.
- 2 . National University of Singapore, Yong Loo Lin School of Medicine, Singapore, Singapore.
- 3 . The University of Sydney, Pharmacy School, Sydney (NSW) Australia.
- 4 . The University of Sidney at Westmead Hospital, Sydney (NSW) Australia.
- 5 . Sydney Institute for Infectious Diseases, The University of Sydney, Sydney (NSW) Australia.
- 6 . Melbourne Health Victorian Tuberculosis Program, Melbourne (VIC) Australia.
- 7 . Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne (VIC) Australia.
- 8 . Infectious Diseases Unit, Istituti Clinici Scientifici Maugeri - IRCCS - Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Italia.
- 9 . Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
- 10 . TB and Acute Respiratory Diseases Section, Department of Communicable Diseases, Directorate General of Disease Surveillance and Control, National TB Programme, MoH Oman, Muscat, Sultanate of Oman.
- 11 . Directorate General for Disease Surveillance and Control, MoH Oman, Muscat, Sultanate of Oman.
- 12 . Nantes Université, CHU Nantes, Service de Pneumologie, L'Institut du Thorax, Nantes, France.
- 13 . Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli - IRCCS - Roma, Italia.
- 14 . Department of Medicine, Dermatology and Therapeutics, Kenyatta University, Nairobi, Kenya.
- 15 . Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
- 16 . Parramatta Chest Clinic, Parramatta (NSW) Australia.
- 17 . TB Reference Centre of Villa Marelli Institute, Niguarda Hospital, Milano, Italia.
- 18 . Vilnius University Hospital Santaros Kilinkos, Vilinius, Lithuania.
- 19 . National Reference Centre for MDR-TB, Serviço de Pneumologia, Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal e Departamento de Ciências da Saúde Pública e Forenses, e Educação Médica, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
- 20 . National TB Control Program, Ministry of Health, Timbu, Bhutan.
- 21 . Programa Integrado de Investigación en Tuberculosis - PII-TB - Sociedad Española de Neumología y Cirugía Torácica - SEPAR - Barcelona, España.
- 22 . Istituto Nazionale per le Malattie Infettive "Lazzaro Spallanzani" - INMI - IRCCS, Roma, Italia.
- 23 . UBT - Higher Education Institution, Prishtina, Kosovo.
- 24 . NGO KeA, Prishtina, Kosovo.
- 25 . Pulmonary Department, Aristotle University of Thessaloniki, "G. Papanikolaou" Hospital, Thessaloniki, Greece.
- 26 . Instituto de Doenças do Tórax, Faculdade de Medicina, Universidade Federal do Rio de Janeiro - UFRJ - Rio de Janeiro (RJ) Brasil.
- 27 . Clinton Health Access Initiative, Phnom Penh, Cambodia.
- 28 . Centro de Investigación, Prevención y Tratamiento de Infecciones Respiratorias -CIPTIR - Hospital Universitario de Monterrey, Universidad Autónoma de Nuevo León, Monterrey, México.
- 29 . Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
- 30 . Damien Foundation, Niamey, Niger.
- 31 . Division of Infectious Diseases and International Health, University of Virginia, Charlottesville (VA) USA.
- 32 . Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
- 33 . Royal London Hospital, Barts Health National Health Service Trust, London, United Kingdom.
- 34 . P.D. Hinduja National Hospital and Medical Research Centre, Mumbai, India.
- 35 . Public Health Consulting Group, Lugano, Switzerland.
- 36 . Faculdade de Medicina, Universidade Federal do Rio Grande do Sul - UFRGS- Porto Alegre, Brasil.
The objective of this study was to describe country-specific lockdown measures and tuberculosis indicators collected during the first year of the COVID-19 pandemic. Data on lockdown/social restrictions (compulsory face masks and hand hygiene; international and local travel restrictions; restrictions to family visits, and school closures) were collected from 24 countries spanning five continents. The majority of the countries implemented multiple lockdowns with partial or full reopening. There was an overall decrease in active tuberculosis, drug-resistant tuberculosis, and latent tuberculosis cases. Although national lockdowns were effective in containing COVID-19 cases, several indicators of tuberculosis were affected during the pandemic.
O objetivo deste estudo foi descrever as medidas de confinamento específicas de cada país e os indicadores de tuberculose coletados durante o primeiro ano da pandemia de COVID-19. Dados referentes a confinamento/restrições sociais (uso obrigatório de máscaras faciais e higiene obrigatória das mãos; restrições a viagens internacionais e locais; restrições a visitas familiares e fechamento das escolas) foram coletados de 24 países em cinco continentes. A maioria dos países implantou múltiplos confinamentos, com reabertura parcial ou total. Houve uma redução geral dos casos de tuberculose ativa, tuberculose resistente e tuberculose latente. Embora os confinamentos nacionais tenham sido eficazes na contenção dos casos de COVID-19, vários indicadores de tuberculose foram afetados durante a pandemia.
MeSH terms
-
COVID-19* / epidemiology
-
COVID-19* / prevention & control
-
Communicable Disease Control
-
Humans
-
Influenza, Human* / epidemiology
-
Pandemics / prevention & control
-
Tuberculosis*